High Content Screening of a Kinase-Focused Library Reveals Compounds Broadly-Active against Dengue Viruses


Autoria(s): Cruz, Deu John M.; Koishi, Andrea Cristine; Taniguchi, Juliana Bosso; Li, Xiaolan; Milan Bonotto, Rafaela; No, Joo Hwan; Kim, Keum Hyun; Baek, Sungmin; Kim, Hee Young; Windisch, Marc Peter; Pamplona Mosimann, Ana Luiza; de Borba, Luana; Liuzzi, Michel; Hansen, Michael Adsetts Edberg; Nunes Duarte dos Santos, Claudia; Freitas-Junior, Lucio Holanda
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

27/05/2014

27/05/2014

01/02/2013

Resumo

Dengue virus is a mosquito-borne flavivirus that has a large impact in global health. It is considered as one of the medically important arboviruses, and developing a preventive or therapeutic solution remains a top priority in the medical and scientific community. Drug discovery programs for potential dengue antivirals have increased dramatically over the last decade, largely in part to the introduction of high-throughput assays. In this study, we have developed an image-based dengue high-throughput/high-content assay (HT/HCA) using an innovative computer vision approach to screen a kinase-focused library for anti-dengue compounds. Using this dengue HT/HCA, we identified a group of compounds with a 4-(1-aminoethyl)-N-methylthiazol-2-amine as a common core structure that inhibits dengue viral infection in a human liver-derived cell line (Huh-7.5 cells). Compounds CND1201, CND1203 and CND1243 exhibited strong antiviral activities against all four dengue serotypes. Plaque reduction and time-of-addition assays suggests that these compounds interfere with the late stage of viral infection cycle. These findings demonstrate that our image-based dengue HT/HCA is a reliable tool that can be used to screen various chemical libraries for potential dengue antiviral candidates. © 2013 Cruz et al.

Identificador

http://dx.doi.org/10.1371/journal.pntd.0002073

PLoS Neglected Tropical Diseases, v. 7, n. 2, 2013.

1935-2727

1935-2735

http://hdl.handle.net/11449/74531

10.1371/journal.pntd.0002073

WOS:000315644900037

2-s2.0-84874781907

2-s2.0-84874781907.pdf

Idioma(s)

eng

Relação

PLoS Neglected Tropical Diseases

Direitos

openAccess

Palavras-Chave #alpha2a interferon #chloroquine #phosphotransferase inhibitor #ribavirin #affinity chromatography #animal cell #antiviral activity #Chikungunya alphavirus #computer model #computer program #controlled study #Dengue virus #dose response #drug structure #genotype #high throughput screening #human #human cell #nonhuman #nucleotide sequence #peptide library #validation process #viral disease immunofluorescence assay #Antiviral Agents #Cell Line #Dengue Virus #Drug Discovery #Hepatocytes #High-Throughput Screening Assays #Humans #Microbial Sensitivity Tests
Tipo

info:eu-repo/semantics/article